NCT07220447 L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance
| NCT ID | NCT07220447 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | City of Hope Medical Center |
| Condition | Hematopoietic and Lymphatic System Neoplasm |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2027-07-09 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
This clinical trial tests the feasibility, best dose, and effectiveness of L-theanine for supporting relaxation and mood among cancer patients in surveillance. L-theanine is a substance found in the leaves of green tea with potential to enhance mental health and well-being. It works by increasing certain chemicals within the body that have been associated with stress reduction, mood stabilization, and improved cognitive performance.
Eligibility Criteria
Inclusion Criteria: * Documented informed consent of the participant and/or legally authorized representative. * Assent, when appropriate, will be obtained per institutional guidelines * Willingness to comply with all study interventions including the use of L-theanine and follow-up assessments * Age: ≥ 18 years * Ability to read and understand English or Spanish for questionnaires * Patients must be a cancer patient who has completed treatment and has been in surveillance for at least 6 months * Participants must not have used any herbs or supplements in the past 30 days * Participants must report an anxiety score of \> 3 on Visual Analog Scale - Anxiety * Participants must not have had any changes to their psychiatric medications within the past 60 days * Women of childbearing potential (WOCBP): negative urine or serum pregnancy test. If the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required * Agreement by females and males of childbear